2020-030

The Carlyle Group Names Simon Dingemans as Managing Director

Investment banking and healthcare veteran will lead Carlyle’s UK Buyout and European Healthcare Activities

London, UK – Global investment firm The Carlyle Group (NASDAQ: CG) today announced that Simon Dingemans has been appointed as a Managing Director of the Carlyle European advisory team, effective immediately. 

Mr. Dingemans will become a senior member of the European buyout team and will be responsible for leading Carlyle’s buyout activities in the UK and healthcare coverage across Europe. He will work closely with European Buyout Co-Heads Marco De Benedetti and Gregor Boehm.

Mr. Dingemans’ appointment follows a varied and distinguished career combining both operational and financial experience. From 2011 to 2019, he was Chief Financial Officer for GlaxoSmithKline plc and a member of the Board, where he drove extensive restructuring and operational improvements as well as a number of significant strategic transactions. Prior to GSK, Mr. Dingemans worked in investment banking for 25 years. Having started his career at SG Warburg, he subsequently joined Goldman Sachs where he became a Managing Director and was a Partner for 10 years as a leader of the European M&A business and Head of UK Investment Banking. Most recently, Mr. Dingemans was Chairman of the Financial Reporting Council.

Marco De Benedetti and Gregor Boehm, Co-Heads of Carlyle Europe Partners, said, “We are delighted to welcome Simon to Carlyle and benefit from his unique background in investment banking and as a FTSE 100 CFO. His appointment strengthens our existing UK team, adding seniority to a country which is strategically important to Carlyle, and his significant healthcare expertise will provide valuable insights across European opportunities.”

Simon Dingemans, Managing Director at Carlyle, said: “I am excited to be joining the Carlyle team and look forward to applying my operational and financial experience to drive value across the existing portfolio as well as finding attractive new opportunities in the UK and the European healthcare sector.”

Carlyle Europe Partners’ latest fund, CEP V, closed in October 2019 raising EUR 6.4bn, exceeding its target by almost EUR 1bn.

About the Carlyle Group
The Carlyle Group (NASDAQ: CG) is a global investment firm with deep industry expertise that deploys private capital across four business segments: Corporate Private Equity, Real Assets, Global Credit and Investment Solutions. With $217 billion of assets under management as of March 31, 2020, Carlyle’s purpose is to invest wisely and create value on behalf of its investors, portfolio companies and the communities in which we live and invest. The Carlyle Group employs more than 1,775 people in 32 offices across six continents. Further information is available at www.carlyle.com. Follow The Carlyle Group on Twitter @OneCarlyle.

Media contacts
Andrew Kenny
Tel: +44 7816 176120
Email: andrew.kenny@carlyle.com